Analysis-Launch of arthritis drug biosimilars ramps up US pressure on pricing ‘middlemen’
By Patrick Wingrove (Reuters) – Cheaper versions of one of the most costly and widely used arthritis treatments in the…
July 25, 2023
Indonesia central bank keeps rates on hold as uncertainties ease
By Gayatri Suroyo and Stefanno Sulaiman JAKARTA (Reuters) -Indonesia’s central bank held policy rates steady for the sixth straight review…
Swiss bank Julius Baer to end business with clients in Russia-letter
By Brenna Hughes Neghaiwi ZURICH (Reuters) -Swiss private bank Julius Baer will end all business with clients based in Russia,…
Spotify’s user growth beats expectations
STOCKHOLM (Reuters) -Spotify Technology SA on Tuesday reported second-quarter results that comfortably beat expectations for both monthly active users and…
Decline in UK manufacturing orders eases in July: CBI
LONDON (Reuters) – British manufacturing orders declined in July at the weakest rate this year, while expectations for increases in…
Marketmind: Big Tech litmus test as Fed gathers
A look at the day ahead in U.S. and global markets from Mike Dolan Buoyant Wall St stocks brace for…
Bayer slashes outlook as glyphosate demand weakens further
By Ludwig Burger and Thomas Escritt (Reuters) -Further deterioration in demand for glyphosate-based weed killers led Bayer to cut its…
The problem with X? Meta, Microsoft, hundreds more own trademarks to new Twitter name
By Blake Brittain (Reuters) – Billionaire Elon Musk’s decision to rebrand Twitter as X could be complicated legally: companies including…
U.S. will be short 67,000 chip workers by 2030, industry group says
By Max A. Cherney (Reuters) – The U.S. semiconductor industry faces a shortfall of roughly 67,000 workers by 2030, according…
Japan still seen missing target to balance primary budget by March 2026
By Tetsushi Kajimoto TOKYO (Reuters) -Japan’s government on Tuesday left its own projections unchanged for achieving a primary budget surplus…